EB-1B Outstanding Researcher Green Card for D.C. and Bethesda Scientists
The EB-1B outstanding researcher category requires a permanent job offer from a U.S. research institution — making it employer-dependent, unlike EB-1A. In the D.C.–Bethesda corridor, the dominant EB-1B sponsors are NIH (for tenure-track positions), Georgetown School of Medicine, GWU School of Medicine, and USUHS (Uniformed Services University). The standard is recognition as outstanding in the field — lower than EB-1A's extraordinary ability and accessible to strong early- and mid-career researchers.
The Bethesda-Rockville-Silver Spring corridor — anchored by the NIH campus, the FDA headquarters, and the University of Maryland — hosts the densest concentration of federal biomedical research infrastructure in the world. EB-1B in this corridor primarily originates from two routes. First, NIH tenure-track: NIH's intramural tenure track offers Tenure-Track Investigator positions that are among the most competitive in U.S. biomedical research. When an intramural researcher converts from a research fellow or postdoctoral position to a Tenure-Track Investigator (TTI), NIH can sponsor EB-1B — the permanent job offer requirement is satisfied by the TTI appointment. The NIH's own tenure review process, peer review documentation, and investigator records constitute a substantial portion of the EB-1B evidence package.
Second, Georgetown and GWU: when Georgetown School of Medicine or GWU School of Medicine or Health Sciences offers a permanent research or faculty position, the institution can sponsor EB-1B for outstanding foreign national researchers. The researcher's publications, citation record, peer review service, and recognition in the field form the evidence base. USUHS (Uniformed Services University of the Health Sciences) similarly sponsors EB-1B for permanent research appointments in defense-relevant health sciences.
NIH Intramural Program
Tenure-Track Investigator (TTI) appointments allow NIH to sponsor EB-1B; the TTI selection process — highly competitive, involving external advisory board review — serves as institutional documentation of outstanding ability; intramural records (NIH Reporter, NIH Record, Branch Chief letters) form the evidence base; NIH's own tenure mid-point review documentation provides organized peer assessments.
Georgetown School of Medicine
Georgetown sponsors EB-1B for faculty at the assistant and associate professor level with permanent appointments; Georgetown's visa office coordinates with outside counsel; publication record, citation profile, peer review service, and research awards form the evidence package; Georgetown's medical school affiliation with MedStar Health and Washington Hospital Center provides access to clinical research infrastructure.
George Washington University School of Medicine and Health Sciences
GWU's research-intensive programs in cancer biology, infectious disease, and health sciences support EB-1B sponsorship for outstanding researchers; the Office of International Programs coordinates immigration status; GWU's proximity to NIH and FDA creates institutional access to collaborative research evidence.
FDA / CDER / CBER / CDRH
FDA sponsors EB-1B for permanent scientific positions within the agency (Staff Fellow → Staff Scientist pathway); FDA Staff Scientists with exceptional records — peer-reviewed publications, FDA advisory committee service, regulatory science awards — can receive EB-1B sponsorship through FDA's Office of Human Resources; evidence includes FDA's own review of the scientist's standing in the regulatory science community.
Children's National Hospital (D.C.)
Children's National Research Institute sponsors EB-1B for outstanding pediatric researchers; affiliated with GWU, it supports EB-1B in subspecialties including neonatology, oncology, and rare diseases; publication record in JAMA Pediatrics, Pediatrics, and subspecialty journals forms the evidence base.
USUHS (Uniformed Services University)
The only federal health sciences university in the U.S.; sponsors EB-1B for permanent faculty positions in biomedical research with defense health relevance; affiliated with Walter Reed National Military Medical Center and the National Capital Consortium; research programs in infectious disease, trauma, and combat casualty care.
Eligibility criteria
EB-1B criteria for Bethesda corridor researchers.
EB-1B requires satisfaction of at least two of six criteria, plus a permanent job offer. The six criteria are distinct from — and generally lower-threshold than — the ten EB-1A criteria. Bethesda corridor researchers typically satisfy three or four.
CRITERION 01
Prizes or awards for excellence
NIH Director's Award, NIH Ruth L. Kirschstein Award, NIAID Intramural Research Award, FDA Commissioner's Special Citation, pediatric society research awards.
CRITERION 02
Membership in associations requiring outstanding achievement
American Society for Clinical Investigation, Association of American Physicians, elected fellowship in AHA, AAN, ASCI; requires nomination and peer election, not simply application.
CRITERION 03
Published material in major media
Profiles in STAT News, The Scientist, Nature News; coverage of research findings in Science or Cell press releases; cited in official NIH or FDA communications.
CRITERION 04
Judging the work of others
NIH study section service; FDA advisory committee membership; editorial board service for specialty journals; peer review for Nature, Science, JAMA, NEJM, Lancet.
CRITERION 05
Original scientific or scholarly contributions
Research cited in FDA approval decisions, CDC clinical guidelines, or NIH disease-specific treatment guidelines; discovery of a molecular mechanism with recognized impact; methodology adopted by other labs documented through citation analysis.
CRITERION 06
Authorship of scholarly articles
Publications in high-impact journals (NEJM, Nature, Cell, JAMA, Lancet, PNAS); citation counts consistent with outstanding standing in the specific research area.
D.C.–Bethesda EB-1B profiles
What qualifying records look like here.
Representative profiles from D.C.–Bethesda EB-1B petitions. Identifying details have been generalized.
Tenure-Track Investigator, NCI
Bethesda
Tumor immunology and T cell exhaustion in solid tumors
14 publications (first- or last-author in Cancer Cell, Nature Immunology, JCI)
2 NIH study section ad hoc reviews
AACR Scholar-in-Training Award
Invited lecture at ASCO Annual Meeting
NIH sponsored EB-1B through the Tenure-Track Investigator appointment. The TTI selection process documentation — advisory board letters, peer assessment summary — was central to the petition. Additional peer review evidence from study section service filled the judging criterion.
Assistant Professor
Georgetown School of Medicine — Dept. of Microbiology and Immunology
HIV latency reversal and cure strategies in primary CD4+ T cells
Georgetown sponsored EB-1B; tenure-track appointment documentation from the School of Medicine served as the permanent job offer. ASM Young Investigator Award satisfied prizes criterion; R01 PI status strengthened the institutional standing argument.
Staff Scientist, FDA/CBER
Silver Spring
Potency assay development for cell and gene therapy products
16 FDA technical reports, 9 peer-reviewed publications
FDA Commissioner's Special Citation
Member of 3 ICH expert working groups (regulatory harmonization)
Presented at ISCT, AABB, and ASGCT
FDA sponsored EB-1B through the Staff Scientist appointment. ICH working group membership satisfied the judging criterion; FDA Commissioner's Special Citation satisfied prizes; peer-reviewed publications in Cytotherapy and Molecular Therapy provided the scholarly articles evidence.
Choosing between pathways
EB-1B vs. EB-1A for D.C. researchers — which path first?
EB-1B and EB-1A are complementary, not competing, green card paths. EB-1B is employer-sponsored — it requires a permanent job offer from a qualifying U.S. research institution. EB-1A is self-petitioned — it requires no employer at all. Both fall in the EB-1 preference category, which is historically current for most nationalities. For D.C.–Bethesda researchers at NIH, Georgetown, or GWU, the most common strategy is to have the employer sponsor EB-1B while the researcher simultaneously self-petitions EB-1A. Two approved I-140s provide maximum flexibility.
For Indian nationals, this parallel strategy is especially important: filing both I-140s as early as possible locks in a priority date in EB-1 (which has minimal backlog for India) and provides two independent approval tracks. If EB-1B is denied, EB-1A proceeds independently. If EB-1B is approved first and the priority date is current, I-485 can be filed without waiting for EB-1A. For researchers early enough in their careers that EB-1A is out of reach, EB-1B is the right first step — with EB-1A as the natural follow-on once the record matures.
FAQ
D.C.–Bethesda EB-1B questions.
EB-1B requires a permanent job offer from a qualifying research institution. A postdoctoral fellowship at NIH is not a permanent appointment, and NIH cannot sponsor EB-1B for postdocs. The EB-1B path opens when NIH offers a permanent Staff Scientist, Staff Clinician, or Tenure-Track Investigator appointment. Before that transition, the right instrument is NIW self-petition (to establish an early priority date) or O-1A (for work authorization while the permanent appointment is sought). The NIW priority date established during the postdoc period can remain the controlling date after the EB-1B I-140 is approved.
Yes. Georgetown's EB-1B sponsorship flows from the hiring department through the Office of International Programs. The department chair or research director must initiate the EB-1B sponsorship request and provide documentation of the permanent appointment. Georgetown's OIP coordinates the actual I-140 filing with outside immigration counsel. The researcher provides the evidence package — publications, citation data, expert letters, peer review records — through counsel. Georgetown does not charge the researcher for the EB-1B filing fee directly, but the petition is subject to USCIS base fees (currently $700 for I-140 plus $2,805 for premium processing if used).
EB-1B requires recognition as "outstanding in the specific academic field" — lower than EB-1A's extraordinary ability (top of the field globally) but higher than NIW's well-positioned standard. The typical EB-1B profile: strong publication record in top journals with growing citations, service on NIH study sections or editorial boards, a research award from an academic society, and recognition by peers in expert letters that specifically describe the researcher's standing relative to others in the subspecialty. For Bethesda corridor researchers, having co-investigators or collaborators at institutions outside NIH write expert letters — because NIH is the employer — is standard practice.
Yes. FDA permanent appointments (Staff Fellow → Staff Scientist pathway) qualify as the permanent job offer for EB-1B, when the appointment is indefinite (not time-limited). A time-limited Staff Fellow appointment does not qualify. When an FDA Staff Fellow converts to a permanent Staff Scientist appointment, FDA can sponsor EB-1B. FDA's Office of Human Resources initiates the process internally; the evidence package draws on FDA's own review of the scientist's standing in regulatory science, plus independent peer review and publications in academic literature. FDA-sponsored EB-1B cases are processed at USCIS like other employer-sponsored EB-1B petitions.
Yes. Parallel petitions in different visa categories are permitted. A Tenure-Track Investigator at NIH can (1) receive NIH EB-1B sponsorship for I-140 and simultaneously (2) file an independent NIW or EB-1A self-petition. The two I-140s are separate proceedings; approval or denial of one does not affect the other. The benefit: two approved I-140s in EB-1 and/or EB-2 categories provide priority date insurance and two independent tracks to I-485. NIH does not object to parallel self-petition filings; researchers should coordinate with NIH's immigration office to avoid procedural conflicts.
